Type i interferons: Diversity of sources, production pathways and effects on immune responses

Current Opinion in Virology

Volumn 1, Issue 6, 2011, Pages 463-475

  Swiecki, Melissa ^a   Colonna, Marco ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REPLICATION;

EID: 82955233182     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2011.10.026     Document Type: Review

References (196)

1. Y. Nagano, and Y. Kojima Immunizing property of vaccinia virus inactivated by ultraviolets rays C R Seances Soc Biol Fil 148 1954 1700 1702
2. J. Lindenmann, D.C. Burke, and A. Isaacs Studies on the production, mode of action and properties of interferon Br J Exp Pathol 38 1957 551 562
3. S. Pestka, C.D. Krause, and M.R. Walter Interferons, interferon-like cytokines, and their receptors Immunol Rev 202 2004 8 32 (Pubitemid 39576902)
4. M. Colonna, G. Trinchieri, and Y.J. Liu Plasmacytoid dendritic cells in immunity Nat Immunol 5 2004 1219 1226 (Pubitemid 41057736)
5. M. Gilliet, W. Cao, and Y.J. Liu Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases Nat Rev Immunol 8 2008 594 606
6. A.L. Blasius, and B. Beutler Intracellular toll-like receptors Immunity 32 2010 305 315
7. J.P. Wang, D.R. Asher, M. Chan, E.A. Kurt-Jones, and R.W. Finberg Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA J Immunol 178 2007 3363 3367 (Pubitemid 46417599)
8. H.K. Lee, J.M. Lund, B. Ramanathan, N. Mizushima, and A. Iwasaki Autophagy-dependent viral recognition by plasmacytoid dendritic cells Science 315 2007 1398 1401 (Pubitemid 46399546)
9. Y. Wang, M. Swiecki, S.A. McCartney, and M. Colonna dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity Immunol Rev 243 2011 74 90
10. M. Swiecki, S.A. McCartney, Y. Wang, and M. Colonna TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes J Leukoc Biol 90 2011 691 701
11. Y. Kumagai, O. Takeuchi, H. Kato, H. Kumar, K. Matsui, E. Morii, K. Aozasa, T. Kawai, and S. Akira Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses Immunity 27 2007 240 252 (Pubitemid 47284930)
12. M. Swiecki, S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual Immunity 33 2010 955 966
13. M. Swiecki, Y. Wang, W. Vermi, S. Gilfillan, R.D. Schreiber, and M. Colonna Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo J Exp Med 2011
14. W. Vermi, S. Fisogni, L. Salogni, L. Scharer, H. Kutzner, S. Sozzani, S. Lonardi, C. Rossini, P. Calzavara-Pinton, and P.E. Leboit Spontaneous regression of highly immunogenic Molluscum contagiosum virus (MCV)-induced skin lesions is associated with plasmacytoid dendritic cells and IFN-DC infiltration J Invest Dermatol 131 2011 426 434
15. G. Gerlini, G. Mariotti, B. Bianchi, and N. Pimpinelli Massive recruitment of type I interferon producing plasmacytoid dendritic cells in varicella skin lesions J Invest Dermatol 126 2006 507 509 (Pubitemid 43323190)
16. S. Sozzani, W. Vermi, A. Del Prete, and F. Facchetti Trafficking properties of plasmacytoid dendritic cells in health and disease Trends Immunol 31 2010 270 277
17. M. Kerkmann, S. Rothenfusser, V. Hornung, A. Towarowski, M. Wagner, A. Sarris, T. Giese, S. Endres, and G. Hartmann Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells J Immunol 170 2003 4465 4474 (Pubitemid 36519951)
18. Y. Kumagai, H. Kumar, S. Koyama, T. Kawai, O. Takeuchi, and S. Akira Cutting edge: TLR-dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells J Immunol 182 2009 3960 3964
19. D. Moskophidis, M. Battegay, M.A. Bruendler, E. Laine, I. Gresser, and R.M. Zinkernagel Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon J Virol 68 1994 1951 1955 (Pubitemid 24065765)
20. N. Sevilla, S. Kunz, A. Holz, H. Lewicki, D. Homann, H. Yamada, K.P. Campbell, J.C. de La Torre, and M.B. Oldstone Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells J Exp Med 192 2000 1249 1260
21. P. Borrow, C.F. Evans, and M.B. Oldstone Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression J Virol 69 1995 1059 1070
22. A. Bergthaler, L. Flatz, A.N. Hegazy, S. Johnson, E. Horvath, M. Lohning, and D.D. Pinschewer Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression Proc Natl Acad Sci U S A 107 2010 21641 21646
23. E.I. Zuniga, L.Y. Liou, L. Mack, M. Mendoza, and M.B. Oldstone Persistent virus infection inhibits type I interferon production by plasmacytoid dendritic cells to facilitate opportunistic infections Cell Host Microbe 4 2008 374 386
24. L.N. Lee, S. Burke, M. Montoya, and P. Borrow Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice J Immunol 182 2009 7178 7189
25. A.H. Broquet, Y. Hirata, C.S. McAllister, and M.F. Kagnoff RIG-I/MDA5/MAVS are required to signal a protective IFN response in rotavirus-infected intestinal epithelium J Immunol 186 2011 1618 1626
26. B. Opitz, A. Rejaibi, B. Dauber, J. Eckhard, M. Vinzing, B. Schmeck, S. Hippenstiel, N. Suttorp, and T. Wolff IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein Cell Microbiol 9 2007 930 938 (Pubitemid 46394904)
27. S. Delhaye, S. Paul, G. Blakqori, M. Minet, F. Weber, P. Staeheli, and Michiels T Neurons produce type I interferon during viral encephalitis Proc Natl Acad Sci U S A 103 2006 7835 7840
28. H.M. Lazear, A.K. Pinto, M.R. Vogt, M. Gale Jr., and M.S. Diamond Beta interferon controls West Nile virus infection and pathogenesis in mice J Virol 85 2011 7186 7194
29. S.A. McCartney, W. Vermi, S. Lonardi, C. Rossini, K. Otero, B. Calderon, S. Gilfillan, M.S. Diamond, E.R. Unanue, and M. Colonna RNA sensor-induced type I IFN prevents diabetes caused by a beta cell-tropic virus in mice J Clin Invest 121 2011 1497 1507
30. J.K. Roth-Cross, S.J. Bender, and S.R. Weiss Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia J Virol 82 2008 9829 9838
31. P.A. Lang, M. Recher, N. Honke, S. Scheu, S. Borkens, N. Gailus, C. Krings, A. Meryk, A. Kulawik, and L. Cervantes-Barragan Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice Hepatology 52 2010 25 32
32. M.L. Eloranta, and G.V. Alm Splenic marginal metallophilic macrophages and marginal zone macrophages are the major interferon-alpha/beta producers in mice upon intravenous challenge with herpes simplex virus Scand J Immunol 49 1999 391 394 (Pubitemid 29185422)
33. J. Louten, N. van Rooijen, and C.A. Biron Type 1 IFN deficiency in the absence of normal splenic architecture during lymphocytic choriomeningitis virus infection J Immunol 177 2006 3266 3272 (Pubitemid 44277846)
34. L. Bar-On, and S. Jung Defining dendritic cells by conditional and constitutive cell ablation Immunol Rev 234 2010 76 89
35. T. Junt, E.A. Moseman, M. Iannacone, S. Massberg, P.A. Lang, M. Boes, K. Fink, S.E. Henrickson, D.M. Shayakhmetov, and N.C. Di Paolo Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells Nature 450 2007 110 114 (Pubitemid 350070574)
36. M. Iannacone, E.A. Moseman, E. Tonti, L. Bosurgi, T. Junt, S.E. Henrickson, S.P. Whelan, L.G. Guidotti, and U.H. von Andrian Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus Nature 465 2010 1079 1083
37. Y. Miyake, K. Asano, H. Kaise, M. Uemura, M. Nakayama, and M. Tanaka Critical role of macrophages in the marginal zone in the suppression of immune responses to apoptotic cell-associated antigens J Clin Invest 117 2007 2268 2278 (Pubitemid 47219572)
38. R. Barbalat, L. Lau, R.M. Locksley, and G.M. Barton Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands Nat Immunol 10 2009 1200 1207
39. G. Fejer, L. Drechsel, J. Liese, U. Schleicher, Z. Ruzsics, N. Imelli, U.F. Greber, S. Keck, B. Hildenbrand, and A. Krug Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo PLoS Pathog 4 2008 e1000208
40. C.E. Andoniou, S.L. van Dommelen, V. Voigt, D.M. Andrews, G. Brizard, C. Asselin-Paturel, T. Delale, K.J. Stacey, G. Trinchieri, and M.A. Degli-Esposti Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity Nat Immunol 6 2005 1011 1019 (Pubitemid 41486186)
41. S. Stockinger, R. Kastner, E. Kernbauer, A. Pilz, S. Westermayer, B. Reutterer, D. Soulat, G. Stengl, C. Vogl, and T. Frenz Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes PLoS Pathog 5 2009 e1000355
42. P. Dresing, S. Borkens, M. Kocur, S. Kropp, and S. Scheu A fluorescence reporter model defines "Tip-DCs" as the cellular source of interferon beta in murine listeriosis PLoS ONE 5 2010 e15567
43. Y. Bao, Y. Han, Z. Chen, S. Xu, and X. Cao IFN-alpha-producing PDCA-1(+) Siglec-H(-) B cells mediate innate immune defense by activating NK cells Eur J Immunol 41 2011 657 668
44. G. Mancuso, M. Gambuzza, A. Midiri, C. Biondo, S. Papasergi, S. Akira, G. Teti, and C. Beninati Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells Nat Immunol 10 2009 587 594
45. N. Gratz, H. Hartweger, U. Matt, F. Kratochvill, M. Janos, S. Sigel, B. Drobits, X.D. Li, S. Knapp, and P. Kovarik Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection PLoS Pathog 7 2011 e1001345
46. B. Opitz, M. Vinzing, V. van Laak, B. Schmeck, G. Heine, S. Gunther, R. Preissner, H. Slevogt, P.D. N'Guessan, and J. Eitel Legionella pneumophila induces IFNbeta in lung epithelial cells via IPS-1 and IRF3, which also control bacterial replication J Biol Chem 281 2006 36173 36179 (Pubitemid 46041351)
47. D. Parker, T.S. Cohen, M. Alhede, B.S. Harfenist, F.J. Martin, and A. Prince Induction of Type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells Am J Respir Cell Mol Biol 2011 (Epub ahead of print)
48. F.J. Martin, M.I. Gomez, D.M. Wetzel, G. Memmi, M. O'Seaghdha, G. Soong, C. Schindler, and A. Prince Staphylococcus aureus activates type I IFN signaling in mice and humans through the Xr repeated sequences of protein A J Clin Invest 119 2009 1931 1939
49. R.M. O'Connell, S.K. Saha, S.A. Vaidya, K.W. Bruhn, G.A. Miranda, B. Zarnegar, A.K. Perry, B.O. Nguyen, T.F. Lane, and T. Taniguchi Type I interferon production enhances susceptibility to Listeria monocytogenes infection J Exp Med 200 2004 437 445 (Pubitemid 39121901)
50. V. Auerbuch, D.G. Brockstedt, N. Meyer-Morse, M. O'Riordan, and D.A. Portnoy Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes J Exp Med 200 2004 527 533 (Pubitemid 39121909)
51. J.A. Carrero, B. Calderon, and E.R. Unanue Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection J Exp Med 200 2004 535 540 (Pubitemid 39121910)
52. T.J. Bauler, J.C. Chase, and C.M. Bosio IFN-beta mediates suppression of IL-12p40 in human dendritic cells following infection with virulent Francisella tularensis J Immunol 187 2011 1845 1855
53. G. Guarda, M. Braun, F. Staehli, A. Tardivel, C. Mattmann, I. Forster, M. Farlik, T. Decker, R.A. Du Pasquier, and P. Romero Type I interferon inhibits interleukin-1 production and inflammasome activation Immunity 34 2011 213 223
54. C.A. Biron Interferons alpha and beta as immune regulators - a new look Immunity 14 2001 661 664 (Pubitemid 32592413)
55. T. Kawai, and S. Akira The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors Nat Immunol 11 2010 373 384
56. M.L. Shinohara, L. Lu, J. Bu, M.B. Werneck, K.S. Kobayashi, L.H. Glimcher, and H. Cantor Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells Nat Immunol 7 2006 498 506
57. K. Honda, H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, and N. Yoshida IRF-7 is the master regulator of type-I interferon-dependent immune responses Nature 434 2005 772 777 (Pubitemid 44739521)
58. K. Honda, H. Yanai, A. Takaoka, and T. Taniguchi Regulation of the type I IFN induction: a current view Int Immunol 17 2005 1367 1378 (Pubitemid 41631313)
59. W. Cao, S. Manicassamy, H. Tang, S.P. Kasturi, A. Pirani, N. Murthy, and B. Pulendran Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway Nat Immunol 9 2008 1157 1164
60. R. Colina, M. Costa-Mattioli, R.J. Dowling, M. Jaramillo, L.H. Tai, C.J. Breitbach, Y. Martineau, O. Larsson, L. Rong, and Y.V. Svitkin Translational control of the innate immune response through IRF-7 Nature 452 2008 323 328 (Pubitemid 351430792)
61. A. Takaoka, H. Yanai, S. Kondo, G. Duncan, H. Negishi, T. Mizutani, S. Kano, K. Honda, Y. Ohba, and T.W. Mak Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors Nature 434 2005 243 249 (Pubitemid 40388058)
62. K. Honda, Y. Ohba, H. Yanai, H. Negishi, T. Mizutani, A. Takaoka, C. Taya, and T. Taniguchi Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction Nature 434 2005 1035 1040 (Pubitemid 40586053)
63. C. Guiducci, G. Ott, J.H. Chan, E. Damon, C. Calacsan, T. Matray, K.D. Lee, R.L. Coffman, and F.J. Barrat Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation J Exp Med 203 2006 1999 2008 (Pubitemid 44188473)
64. K. Tabeta, K. Hoebe, E.M. Janssen, X. Du, P. Georgel, K. Crozat, S. Mudd, N. Mann, S. Sovath, and J. Goode The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9 Nat Immunol 7 2006 156 164 (Pubitemid 43135881)
65. M.M. Brinkmann, E. Spooner, K. Hoebe, B. Beutler, H.L. Ploegh, and Y.M. Kim The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling J Cell Biol 177 2007 265 275 (Pubitemid 46658638)
66. ••].
67. A.L. Blasius, C.N. Arnold, P. Georgel, S. Rutschmann, Y. Xia, P. Lin, C. Ross, X. Li, N.G. Smart, and B. Beutler Slc15a4, AP-3, and Hermansky-Pudlak syndrome proteins are required for Toll-like receptor signaling in plasmacytoid dendritic cells Proc Natl Acad Sci U S A 107 2010 19973 19978
68. B. Park, M.M. Brinkmann, E. Spooner, C.C. Lee, Y.M. Kim, and H.L. Ploegh Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9 Nat Immunol 9 2008 1407 1414
69. S.E. Ewald, B.L. Lee, L. Lau, K.E. Wickliffe, G.P. Shi, H.A. Chapman, and G.M. Barton The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor 456 2008 658 662
70. S.E. Ewald, A. Engel, J. Lee, M. Wang, M. Bogyo, and G.M. Barton Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase J Exp Med 208 2011 643 651
71. M. Yoshizaki, A. Tazawa, E. Kasumi, S. Sasawatari, K. Itoh, T. Dohi, T. Sasazuki, K. Inaba, A.P. Makrigiannis, and N. Toyama-Sorimachi Spatiotemporal regulation of intracellular trafficking of Toll-like receptor 9 by an inhibitory receptor, Ly49Q Blood 114 2009 1518 1527
72. B. Park, L. Buti, S. Lee, T. Matsuwaki, E. Spooner, M.M. Brinkmann, M. Nishihara, and H.L. Ploegh Granulin is a soluble cofactor for toll-like receptor 9 signaling Immunity 34 2011 505 513
73. A.M. Avalos, and H.L. Ploegh Competition by inhibitory oligonucleotides prevents binding of CpG to C-terminal TLR9 Eur J Immunol 41 2011 2820 2827
74. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, and S. Bauer Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8 Science 303 2004 1526 1529 (Pubitemid 38314424)
75. J. Martinez, X. Huang, and Y. Yang Toll-like receptor 8-mediated activation of murine plasmacytoid dendritic cells by vaccinia viral DNA Proc Natl Acad Sci U S A 107 2010 6442 6447
76. O. Takeuchi, and S. Akira Recognition of viruses by innate immunity Immunol Rev 220 2007 214 224 (Pubitemid 350045565)
77. A. Pichlmair, and C. Reis e Sousa Innate recognition of viruses Immunity 27 2007 370 383 (Pubitemid 47418682)
78. L. Alexopoulou, A.C. Holt, R. Medzhitov, and R.A. Flavell Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3 Nature 413 2001 732 738 (Pubitemid 33009951)
79. O. Schulz, S.S. Diebold, M. Chen, T.I. Naslund, M.A. Nolte, L. Alexopoulou, Y.T. Azuma, R.A. Flavell, P. Liljestrom, and C. Reis e Sousa Toll-like receptor 3 promotes cross-priming to virus-infected cells Nature 433 2005 887 892 (Pubitemid 40314900)
80. L. Gitlin, W. Barchet, S. Gilfillan, M. Cella, B. Beutler, R.A. Flavell, M.S. Diamond, and M. Colonna Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus Proc Natl Acad Sci U S A 103 2006 8459 8464 (Pubitemid 43838477)
81. M. Yamamoto, S. Sato, K. Mori, K. Hoshino, O. Takeuchi, K. Takeda, and S. Akira Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling J Immunol 169 2002 6668 6672 (Pubitemid 36899248)
82. H. Oshiumi, M. Matsumoto, K. Funami, T. Akazawa, and T. Seya TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction Nat Immunol 4 2003 161 167 (Pubitemid 36193018)
83. P.H. Tseng, A. Matsuzawa, W. Zhang, T. Mino, D.A. Vignali, and M. Karin Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines Nat Immunol 11 2010 70 75
84. K. Tabeta, P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, and J. Goode Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection Proc Natl Acad Sci U S A 101 2004 3516 3521 (Pubitemid 38338227)
85. S.Y. Zhang, E. Jouanguy, V. Sancho-Shimizu, H. von Bernuth, K. Yang, L. Abel, C. Picard, A. Puel, and J.L. Casanova Human Toll-like receptor-dependent induction of interferons in protective immunity to viruses Immunol Rev 220 2007 225 236 (Pubitemid 350045567)
86. S.Y. Zhang, E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, and A. Puel TLR3 deficiency in patients with herpes simplex encephalitis Science 317 2007 1522 1527 (Pubitemid 47417427)
87. J.L. Casanova, L. Abel, and L. Quintana-Murci Human TLRs and IL-1Rs in host defense: natural insights from evolutionary, epidemiological, and clinical genetics Annu Rev Immunol 29 2011 447 491
88. V. Sancho-Shimizu, S.Y. Zhang, L. Abel, M. Tardieu, F. Rozenberg, E. Jouanguy, and J.L. Casanova Genetic susceptibility to herpes simplex virus 1 encephalitis in mice and humans Curr Opin Allergy Clin Immunol 7 2007 495 505 (Pubitemid 350076444)
89. Y. Guo, M. Audry, M. Ciancanelli, L. Alsina, J. Azevedo, M. Herman, E. Anguiano, V. Sancho-Shimizu, L. Lorenzo, and E. Pauwels Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity J Exp Med 208 2011 2083 2098
90. E. Szomolanyi-Tsuda, X. Liang, R.M. Welsh, E.A. Kurt-Jones, and R.W. Finberg Role for TLR2 in NK cell-mediated control of murine cytomegalovirus in vivo J Virol 80 2006 4286 4291
91. S. Chang, A. Dolganiuc, and G. Szabo Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins J Leukoc Biol 82 2007 479 487 (Pubitemid 47367138)
92. E.A. Kurt-Jones, M. Chan, S. Zhou, J. Wang, G. Reed, R. Bronson, M.M. Arnold, D.M. Knipe, and R.W. Finberg Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis Proc Natl Acad Sci U S A 101 2004 1315 1320 (Pubitemid 38182686)
93. A. Sato, M.M. Linehan, and A. Iwasaki Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells Proc Natl Acad Sci U S A 103 2006 17343 17348 (Pubitemid 44788971)
94. K.W. Boehme, M. Guerrero, and T. Compton Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells J Immunol 177 2006 7094 7102 (Pubitemid 44715077)
95. T. Compton, E.A. Kurt-Jones, K.W. Boehme, J. Belko, E. Latz, D.T. Golenbock, and R.W. Finberg Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2 J Virol 77 2003 4588 4596 (Pubitemid 36402808)
96. K. Bieback, E. Lien, I.M. Klagge, E. Avota, J. Schneider-Schaulies, W.P. Duprex, H. Wagner, C.J. Kirschning, V. Ter Meulen, and S. Schneider-Schaulies Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling J Virol 76 2002 8729 8736 (Pubitemid 34864068)
97. J. Zhu, J. Martinez, X. Huang, and Y. Yang Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta Blood 109 2007 619 625 (Pubitemid 46105962)
98. S. Zhou, E.A. Kurt-Jones, L. Mandell, A. Cerny, M. Chan, D.T. Golenbock, and R.W. Finberg MyD88 is critical for the development of innate and adaptive immunity during acute lymphocytic choriomeningitis virus infection Eur J Immunol 35 2005 822 830 (Pubitemid 40425538)
99. Y.M. Loo, and M. Gale Jr. Immune signaling by RIG-I-like receptors Immunity 34 2011 680 692
100. M. Yoneyama, and T. Fujita RNA recognition and signal transduction by RIG-I-like receptors Immunol Rev 227 2009 54 65
101. C. Wilkins, and M. Gale Jr. Recognition of viruses by cytoplasmic sensors Curr Opin Immunol 22 2010 41 47
102. E. Meylan, J. Tschopp, and M. Karin Intracellular pattern recognition receptors in the host response Nature 442 2006 39 44 (Pubitemid 44064203)
103. T. Kawai, K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K.J. Ishii, O. Takeuchi, and S. Akira IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction Nat Immunol 6 2005 981 988 (Pubitemid 41486182)
104. R.B. Seth, L. Sun, C.K. Ea, and Z.J. Chen Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3 Cell 122 2005 669 682 (Pubitemid 41242633)
105. L.G. Xu, Y.Y. Wang, K.J. Han, L.Y. Li, Z. Zhai, and H.B. Shu VISA is an adapter protein required for virus-triggered IFN-beta signaling Mol Cell 19 2005 727 740 (Pubitemid 41316668)
106. H. Kumar, T. Kawai, H. Kato, S. Sato, K. Takahashi, C. Coban, M. Yamamoto, S. Uematsu, K.J. Ishii, and O. Takeuchi Essential role of IPS-1 in innate immune responses against RNA viruses J Exp Med 203 2006 1795 1803 (Pubitemid 44036284)
107. S. Sharma, B.R. tenOever, N. Grandvaux, G.P. Zhou, R. Lin, and J. Hiscott Triggering the interferon antiviral response through an IKK-related pathway Science 300 2003 1148 1151 (Pubitemid 36583100)
108. S.K. Saha, E.M. Pietras, J.Q. He, J.R. Kang, S.Y. Liu, G. Oganesyan, A. Shahangian, B. Zarnegar, T.L. Shiba, and Y. Wang Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif EMBO J 25 2006 3257 3263 (Pubitemid 44141784)
109. G. Oganesyan, S.K. Saha, B. Guo, J.Q. He, A. Shahangian, B. Zarnegar, A. Perry, and G. Cheng Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response Nature 439 2006 208 211 (Pubitemid 43083142)
110. S. Balachandran, E. Thomas, and G.N. Barber A FADD-dependent innate immune mechanism in mammalian cells Nature 432 2004 401 405 (Pubitemid 39551675)
111. K. Takahashi, T. Kawai, H. Kumar, S. Sato, S. Yonehara, and S. Akira Roles of caspase-8 and caspase-10 in innate immune responses to double-stranded RNA J Immunol 176 2006 4520 4524
112. E. Dixit, S. Boulant, Y. Zhang, A.S. Lee, C. Odendall, B. Shum, N. Hacohen, Z.J. Chen, S.P. Whelan, and M. Fransen Peroxisomes are signaling platforms for antiviral innate immunity Cell 141 2010 668 681
113. A. Pichlmair, O. Schulz, C.P. Tan, T.I. Naslund, P. Liljestrom, F. Weber, and C. Reis e Sousa RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates Science 314 2006 997 1001 (Pubitemid 44749946)
114. V. Hornung, J. Ellegast, S. Kim, K. Brzozka, A. Jung, H. Kato, H. Poeck, S. Akira, K.K. Conzelmann, and M. Schlee 5′-Triphosphate RNA is the ligand for RIG-I Science 314 2006 994 997
115. A. Pichlmair, O. Schulz, C.P. Tan, J. Rehwinkel, H. Kato, O. Takeuchi, S. Akira, M. Way, G. Schiavo, and C. Reis e Sousa Activation of MDA5 requires higher-order RNA structures generated during virus infection J Virol 83 2009 10761 10769
116. M. Schlee, A. Roth, V. Hornung, C.A. Hagmann, V. Wimmenauer, W. Barchet, C. Coch, M. Janke, A. Mihailovic, and G. Wardle Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus Immunity 31 2009 25 34
117. H. Kato, O. Takeuchi, E. Mikamo-Satoh, R. Hirai, T. Kawai, K. Matsushita, A. Hiiragi, T.S. Dermody, T. Fujita, and S. Akira Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5 J Exp Med 205 2008 1601 1610 (Pubitemid 351962024)
118. S. Cui, K. Eisenacher, A. Kirchhofer, K. Brzozka, A. Lammens, K. Lammens, T. Fujita, K.K. Conzelmann, A. Krug, and K.P. Hopfner The C-terminal regulatory domain is the RNA 5′-triphosphate sensor of RIG-I Mol Cell 29 2008 169 179 (Pubitemid 351172822)
119. ••] .
120. ••].
121. ••].
122. ••].
123. ••].
124. ••].
125. ••].
126. F. Jiang, A. Ramanathan, M.T. Miller, G.Q. Tang, M. Gale, S.S. Patel, and J. Marcotrigiano Structural basis of RNA recognition and activation by innate immune receptor RIG-I Nature 2011 (Epub ahead of print)
127. ••].
128. Y.H. Chiu, J.B. Macmillan, and Z.J. Chen RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway Cell 138 2009 576 591
129. T. Satoh, H. Kato, Y. Kumagai, M. Yoneyama, S. Sato, K. Matsushita, T. Tsujimura, T. Fujita, S. Akira, and O. Takeuchi LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses Proc Natl Acad Sci U S A 107 2010 1512 1517
130. T. Venkataraman, M. Valdes, R. Elsby, S. Kakuta, G. Caceres, S. Saijo, Y. Iwakura, and G.N. Barber Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses J Immunol 178 2007 6444 6455 (Pubitemid 46717428)
131. S. Rothenfusser, N. Goutagny, G. DiPerna, M. Gong, B.G. Monks, A. Schoenemeyer, M. Yamamoto, S. Akira, and K.A. Fitzgerald The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I J Immunol 175 2005 5260 5268 (Pubitemid 41456411)
132. K. Arimoto, H. Takahashi, T. Hishiki, H. Konishi, T. Fujita, and K. Shimotohno Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125 Proc Natl Acad Sci U S A 104 2007 7500 7505 (Pubitemid 47185935)
133. M.U. Gack, Y.C. Shin, C.H. Joo, T. Urano, C. Liang, L. Sun, O. Takeuchi, S. Akira, Z. Chen, and S. Inoue TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity Nature 446 2007 916 920 (Pubitemid 46633167)
134. H. Oshiumi, M. Miyashita, N. Inoue, M. Okabe, M. Matsumoto, and T. Seya The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection Cell Host Microbe 8 2010 496 509
135. P. Wang, A. Arjona, Y. Zhang, H. Sultana, J. Dai, L. Yang, P.M. LeBlanc, K. Doiron, M. Saleh, and E. Fikrig Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I Nat Immunol 11 2010 912 919
136. A. Rajput, A. Kovalenko, K. Bogdanov, S.H. Yang, T.B. Kang, J.C. Kim, J. Du, and D. Wallach RIG-I RNA helicase activation of IRF3 transcription factor is negatively regulated by caspase-8-mediated cleavage of the RIP1 protein Immunity 34 2011 340 351
137. Z. Mi, J. Fu, Y. Xiong, and H. Tang SUMOylation of RIG-I positively regulates the type I interferon signaling Protein Cell 1 2010 275 283
138. J. Fu, Y. Xiong, Y. Xu, G. Cheng, and H. Tang MDA5 is SUMOylated by PIAS2beta in the upregulation of type I interferon signaling Mol Immunol 48 2011 415 422
139. C.B. Moore, D.T. Bergstralh, J.A. Duncan, Y. Lei, T.E. Morrison, A.G. Zimmermann, M.A. Accavitti-Loper, V.J. Madden, L. Sun, and Z. Ye NLRX1 is a regulator of mitochondrial antiviral immunity Nature 451 2008 573 577 (Pubitemid 351186265)
140. I.C. Allen, C.B. Moore, M. Schneider, Y. Lei, B.K. Davis, M.A. Scull, D. Gris, K.E. Roney, A.G. Zimmermann, and J.B. Bowzard NLRX1 protein attenuates inflammatory responses to infection by interfering with the RIG-I-MAVS and TRAF6-NF-kappaB signaling pathways Immunity 34 2011 854 865
141. J. Hou, P. Wang, L. Lin, X. Liu, F. Ma, H. An, Z. Wang, and X. Cao MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2 J Immunol 183 2009 2150 2158
142. W.B. Cardenas, Y.M. Loo, M. Gale Jr., A.L. Hartman, C.R. Kimberlin, L. Martinez-Sobrido, E.O. Saphire, and C.F. Basler Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling J Virol 80 2006 5168 5178
143. K.C. Prins, W.B. Cardenas, and C.F. Basler Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1 J Virol 83 2009 3069 3077
144. J. Andrejeva, K.S. Childs, D.F. Young, T.S. Carlos, N. Stock, S. Goodbourn, and R.E. Randall The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter Proc Natl Acad Sci U S A 101 2004 17264 17269 (Pubitemid 39627808)
145. K.S. Childs, J. Andrejeva, R.E. Randall, and S. Goodbourn Mechanism of mda-5 inhibition by paramyxovirus V proteins J Virol 83 2009 1465 1473
146. G.N. Barber Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses Curr Opin Immunol 23 2011 10 20
147. A. Takaoka, Z. Wang, M.K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, and K. Honda DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response Nature 448 2007 501 505 (Pubitemid 47123520)
148. Z. Wang, M.K. Choi, T. Ban, H. Yanai, H. Negishi, Y. Lu, T. Tamura, A. Takaoka, K. Nishikura, and T. Taniguchi Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules Proc Natl Acad Sci U S A 105 2008 5477 5482 (Pubitemid 351753888)
149. K.J. Ishii, T. Kawagoe, S. Koyama, K. Matsui, H. Kumar, T. Kawai, S. Uematsu, O. Takeuchi, F. Takeshita, and C. Coban TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines Nature 451 2008 725 729 (Pubitemid 351220566)
150. J. Lippmann, S. Rothenburg, N. Deigendesch, J. Eitel, K. Meixenberger, V. van Laak, H. Slevogt, P.D. N'Guessan, S. Hippenstiel, and T. Chakraborty IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI) Cell Microbiol 10 2008 2579 2588
151. L. Unterholzner, S.E. Keating, M. Baran, K.A. Horan, S.B. Jensen, S. Sharma, C.M. Sirois, T. Jin, E. Latz, and T.S. Xiao IFI16 is an innate immune sensor for intracellular DNA Nat Immunol 11 2010 997 1004
152. ••].
153. ••].
154. H. Ishikawa, Z. Ma, and G.N. Barber STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity Nature 461 2009 788 792
155. H. Yanai, T. Ban, Z. Wang, M.K. Choi, T. Kawamura, H. Negishi, M. Nakasato, Y. Lu, S. Hangai, and R. Koshiba HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses Nature 462 2009 99 103
156. J. Tian, A.M. Avalos, S.Y. Mao, B. Chen, K. Senthil, H. Wu, P. Parroche, S. Drabic, D. Golenbock, and C. Sirois Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE Nat Immunol 8 2007 487 496 (Pubitemid 46605917)
157. P. Yang, H. An, X. Liu, M. Wen, Y. Zheng, Y. Rui, and X. Cao The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway Nat Immunol 11 2010 487 494
158. ••].
159. ••].
160. Z. Zhang, B. Yuan, M. Bao, N. Lu, T. Kim, and Y.J. Liu The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells Nat Immunol 12 2011 959 965
161. T.L. Roberts, A. Idris, J.A. Dunn, G.M. Kelly, C.M. Burnton, S. Hodgson, L.L. Hardy, V. Garceau, M.J. Sweet, and I.L. Ross HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA Science 323 2009 1057 1060
162. T. Fernandes-Alnemri, J.W. Yu, P. Datta, J. Wu, and E.S. Alnemri AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA Nature 458 2009 509 513
163. T. Burckstummer, C. Baumann, S. Bluml, E. Dixit, G. Durnberger, H. Jahn, M. Planyavsky, M. Bilban, J. Colinge, and K.L. Bennett An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome Nat Immunol 10 2009 266 272
164. V.A. Rathinam, Z. Jiang, S.N. Waggoner, S. Sharma, L.E. Cole, L. Waggoner, S.K. Vanaja, B.G. Monks, S. Ganesan, and E. Latz The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses Nat Immunol 11 2010 395 402
165. I.C. Allen, M.A. Scull, C.B. Moore, E.K. Holl, E. McElvania-TeKippe, D.J. Taxman, E.H. Guthrie, R.J. Pickles, and J.P. Ting The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA Immunity 30 2009 556 565
166. T. Ichinohe, H.K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki Inflammasome recognition of influenza virus is essential for adaptive immune responses J Exp Med 206 2009 79 87
167. P.G. Thomas, P. Dash, J.R. Aldridge Jr., A.H. Ellebedy, C. Reynolds, A.J. Funk, W.J. Martin, M. Lamkanfi, R.J. Webby, and K.L. Boyd The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1 Immunity 30 2009 566 575
168. D.A. Muruve, V. Petrilli, A.K. Zaiss, L.R. White, S.A. Clark, P.J. Ross, R.J. Parks, and J. Tschopp The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response Nature 452 2008 103 107 (Pubitemid 351355095)
169. T.D. Kanneganti, N. Ozoren, M. Body-Malapel, A. Amer, J.H. Park, L. Franchi, J. Whitfield, W. Barchet, M. Colonna, and P. Vandenabeele Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 Nature 440 2006 233 236 (Pubitemid 43372103)
170. T.D. Kanneganti, M. Body-Malapel, A. Amer, J.H. Park, J. Whitfield, L. Franchi, Z.F. Taraporewala, D. Miller, J.T. Patton, and N. Inohara Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA J Biol Chem 281 2006 36560 36568 (Pubitemid 46042123)
171. E. Elinav, T. Strowig, J. Henao-Mejia, and R.A. Flavell Regulation of the antimicrobial response by NLR proteins Immunity 34 2011 665 679
172. K. Schroder, and J. Tschopp The inflammasomes Cell 140 2010 821 832
173. T.D. Kanneganti Central roles of NLRs and inflammasomes in viral infection Nat Rev Immunol 10 2010 688 698
174. G. Trinchieri Type I interferon: friend or foe? J Exp Med 207 2010 2053 2063
175. A. Garcia-Sastre, and C.A. Biron Type 1 interferons and the virus-host relationship: a lesson in detente Science 312 2006 879 882 (Pubitemid 43727313)
176. P. Marrack, J. Kappler, and T. Mitchell Type I interferons keep activated T cells alive J Exp Med 189 1999 521 530
177. A. Le Bon, and D.F. Tough Links between innate and adaptive immunity via type I interferon Curr Opin Immunol 14 2002 432 436 (Pubitemid 34671244)
178. G.A. Kolumam, S. Thomas, L.J. Thompson, J. Sprent, and K. Murali-Krishna Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection J Exp Med 202 2005 637 650 (Pubitemid 41248415)
179. M.F. Mescher, J.M. Curtsinger, P. Agarwal, K.A. Casey, M. Gerner, C.D. Hammerbeck, F. Popescu, and Z. Xiao Signals required for programming effector and memory development by CD8+ T cells Immunol Rev 211 2006 81 92 (Pubitemid 43882963)
180. G. Jego, A.K. Palucka, J.P. Blanck, C. Chalouni, V. Pascual, and J. Banchereau Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6 Immunity 19 2003 225 234 (Pubitemid 37011337)
181. H. Poeck, M. Wagner, J. Battiany, S. Rothenfusser, D. Wellisch, V. Hornung, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann Plasmacytoid dendritic cells, antigen, and CpG-C license human B cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help Blood 103 2004 3058 3064 (Pubitemid 38451681)
182. L.P. Cousens, R. Peterson, S. Hsu, A. Dorner, J.D. Altman, R. Ahmed, and C.A. Biron Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection J Exp Med 189 1999 1315 1328
183. U. Steinhoff, U. Muller, A. Schertler, H. Hengartner, M. Aguet, and R.M. Zinkernagel Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice J Virol 69 1995 2153 2158
184. K. Fink, K.S. Lang, N. Manjarrez-Orduno, T. Junt, B.M. Senn, M. Holdener, S. Akira, R.M. Zinkernagel, and H. Hengartner Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses Eur J Immunol 36 2006 2094 2105 (Pubitemid 44251755)
185. M. Montoya, G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli, P. Borrow, and D.F. Tough Type I interferons produced by dendritic cells promote their phenotypic and functional activation Blood 99 2002 3263 3271 (Pubitemid 34525306)
186. M.P. Longhi, C. Trumpfheller, J. Idoyaga, M. Caskey, I. Matos, C. Kluger, A.M. Salazar, M. Colonna, and R.M. Steinman Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant J Exp Med 206 2009 1589 1602
187. A. Le Bon, N. Etchart, C. Rossmann, M. Ashton, S. Hou, D. Gewert, P. Borrow, and D.F. Tough Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon Nat Immunol 4 2003 1009 1015 (Pubitemid 37265922)
188. C. Asselin-Paturel, G. Brizard, K. Chemin, A. Boonstra, A. O'Garra, A. Vicari, and G. Trinchieri Type I interferon dependence of plasmacytoid dendritic cell activation and migration J Exp Med 201 2005 1157 1167 (Pubitemid 40528442)
189. B. Pulendran, K. Palucka, and J. Banchereau Sensing pathogens and tuning immune responses Science 293 2001 253 256 (Pubitemid 32694733)
190. S.M. Santini, C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Di Pucchio, and F. Belardelli Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice J Exp Med 191 2000 1777 1788 (Pubitemid 30331574)
191. •].
192. •].
193. •].
194. M.A. Essers, S. Offner, W.E. Blanco-Bose, Z. Waibler, U. Kalinke, M.A. Duchosal, and A. Trumpp IFNalpha activates dormant haematopoietic stem cells in vivo Nature 458 2009 904 908
195. J.P. Herbeuval, and G.M. Shearer HIV-1 immunopathogenesis: how good interferon turns bad Clin Immunol 123 2007 121 128 (Pubitemid 46590066)
196. A. Boasso, and G.M. Shearer Chronic innate immune activation as a cause of HIV-1 immunopathogenesis Clin Immunol 126 2008 235 242 (Pubitemid 351221427)